8月18日，京东健康盘中下跌3.48%，报37.76港元/股，成交额3751.39万港元。
消息面上，野村证券于8月17日将京东健康目标价从67港元下调至60港元，维持买入评级。尽管公司8月13日发布的中期业绩表现亮眼——上半年总收入408.88亿元人民币，同比增长15.9%；股东应占溢利34.37亿元，同比增长32.37%；Non-IFRS经营利润同比增长40.3%——但母公司京东集团此前因营收负增长大跌超10%，持续拖累京东系个股。当前互联网与直销零售板块整体走弱，阿里健康跌2.59%、平安好医生跌2.5%、京东集团跌1.95%、美团跌1.71%，板块情绪偏弱背景下京东健康承压回调。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.